Cronos (CRON) Capital Expenditures Growth (1y) (2020 - 2026)
Cronos (CRON) Capital Expenditures Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 32.28% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -38.20% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -15.72% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 32.98% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -6.34% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -86.92% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -21.54% |
| 10 | Cronos | 1.04 Bn | 267.78 Mn | 19.15 Mn | -87.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -87.71% |
| Dec 31, 2025 | -39.63% |
| Sep 30, 2025 | -30.12% |
| Jun 30, 2025 | 426.34% |
| Mar 31, 2025 | 785.03% |
| Dec 31, 2024 | 190.89% |
| Sep 30, 2024 | 9,474.63% |
| Jun 30, 2024 | 47.57% |
| Mar 31, 2024 | 114.43% |
| Dec 31, 2023 | 234.62% |
| Sep 30, 2023 | -49.62% |
| Jun 30, 2023 | -67.22% |
| Mar 31, 2023 | 13.08% |
| Dec 31, 2022 | -26.17% |
| Sep 30, 2022 | -94.23% |
| Jun 30, 2022 | -9.60% |
| Mar 31, 2022 | -89.36% |
| Dec 31, 2021 | -95.11% |
| Sep 30, 2021 | -71.16% |
| Jun 30, 2021 | -75.96% |